Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO). Med (New York, N.Y.) Mylonakis, E., Lutaakome, J., Jain, M. K., Rogers, A. J., Molto, J., Benet, S., Mourad, A., Files, D. C., Mugerwa, H., Kityo, C., Kiweewa, F., Nalubega, M. G., Kitonsa, J., Nabenkema, E., Murray, D. D., Braun, D., Kamel, D., Higgs, E. S., Hatlen, T. J., Kan, V. L., Sanchez, A., Tierney, J., Denner, E., Wentworth, D., Babiker, A. G., Davey, V. J., Gelijns, A. C., Matthews, G. V., Thompson, B. T., Lane, H. C., Neaton, J. D., Lundgren, J. D. 2022; 3 (8): 531-537

Abstract

The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.

View details for DOI 10.1016/j.medj.2022.07.003

View details for PubMedID 35963234